药品医保支付价格形成机制的国际经验及启示
x

请在关注微信后,向客服人员索取文件

篇名: 药品医保支付价格形成机制的国际经验及启示
TITLE:
摘要: 目的:为我国制定合理的药品医保支付价格提供借鉴。方法:通过检索分析国内外正式发表的学术文章、官方网站和政府文件、新闻报道等资料和知情人访谈,总结国际主要药品医保支付价格形成机制,高值药可持续的公平可及的解决方式,为我国制定合理的药品价格政策提出建议。结果与结论:国际通用的医药支付价格的确定依据为内部参考定价法、增量成本-效果评价法、外部参考定价法。国际社会还采取以公平药价计划、药品专利池、开源药物研发组织等形式促进高值药可持续地公平可及。我国实现全民医保目标后,应积极探索制定合理的医保支付价格。可以在仿制药质量和临床疗效一致性评价后,采用内部参考定价法确定有仿制药竞争品种的支付标准,采用外部参考定价法或增量成本-效果评价法确定创新专利药品价格谈判的参考价格,对高值药物采用公平定价的理念。
ABSTRACT: OBJECTIVE: To provide reference for setting reasonable medicines insurance payment price in China. METHODS: We retrieved and analyzed academic articles formally published at home and abroad, official websites and government documents, summarized.medicines insurance payment pricing mechanism as well as fair solutions to high-cost medicines, so as to put forward the suggestions to formulate reasonable medicines pricing policy in China. RESULTS&CONCLUSIONS: The international medicines payment prices are usually determined by internal reference pricing method, incremental cost-effectiveness evaluation method and external reference pricing method. The sustainable and fair accessibility of high-cost medicines are promoted by fair medicines pricing program, medicines patent pool, open source medicines discovery znitiative and so on. After the goal of universal health care has been achieved in china, reasonable medical insurance payment price should be explored and formulated. It is necessary to adopt, internal reference pricing method to determine the payment standard of completitive eneric products, external reference pricing method or incremental cost-effectiveness evaluation method to determine the reference price for price negotiation of the innovative patented medicines; the concept of fair pricing for high-cost medicines.
期刊: 2017年第28卷第24期
作者: 陈吟,孙静,刘远立
AUTHORS: CHEN Yin,SUN Jing,LIU Yuanli
关键字: 药品价格;价格形成机制;国际经验
KEYWORDS: Medicines price; Pricing mechanism; International experience
总下载数: 9 次
本日下载数: 0次
本月下载数: 0次
文件大小: 619.60Kb

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!